141 related articles for article (PubMed ID: 18787546)
21. Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy.
Speeckaert R; van Geel N; Vermaelen KV; Lambert J; Van Gele M; Speeckaert MM; Brochez L
Pigment Cell Melanoma Res; 2011 Apr; 24(2):334-44. PubMed ID: 21029398
[TBL] [Abstract][Full Text] [Related]
22. [Phenotypic plasticity of neural crest-derived melanocytes and Schwann cells].
Dupin E
Biol Aujourdhui; 2011; 205(1):53-61. PubMed ID: 21501576
[TBL] [Abstract][Full Text] [Related]
23. Current concepts of the biology of human cutaneous malignant melanoma.
Clark WH; Mastrangelo MJ; Ainsworth AM; Berd D; Bellet RE; Bernardino EA
Adv Cancer Res; 1977; 24():267-338. PubMed ID: 322460
[No Abstract] [Full Text] [Related]
24. Molecular pathogenesis of sporadic melanoma and melanoma-initiating cells.
Kong Y; Kumar SM; Xu X
Arch Pathol Lab Med; 2010 Dec; 134(12):1740-9. PubMed ID: 21128770
[TBL] [Abstract][Full Text] [Related]
25. Characteristic distribution of melanin columns in the cornified layer of acquired acral nevus: an important clue for histopathologic differentiation from early acral melanoma.
Saida T; Koga H; Goto Y; Uhara H
Am J Dermatopathol; 2011 Jul; 33(5):468-73. PubMed ID: 21552104
[TBL] [Abstract][Full Text] [Related]
26. Melanocytic nevi and malignant melanoma.
Metcalf JS; Maize JC
Dermatol Clin; 1985 Apr; 3(2):217-24. PubMed ID: 3830485
[TBL] [Abstract][Full Text] [Related]
27. Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis.
Alexandrescu DT; Kauffman CL; Jatkoe TA; Hartmann DP; Vener T; Wang H; Derecho C; Rajpurohit Y; Wang Y; Palma JF
J Invest Dermatol; 2010 Jul; 130(7):1887-92. PubMed ID: 20357814
[TBL] [Abstract][Full Text] [Related]
28. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
29. On the causes of melanomas.
Nordlund JJ; Lerner AB
Am J Pathol; 1977 Nov; 89(2):443-8. PubMed ID: 920779
[TBL] [Abstract][Full Text] [Related]
30. Melanoma Development: Current Knowledge on Melanoma Pathogenesis.
Lugović-Mihić L; Ćesić D; Vuković P; Novak Bilić G; Šitum M; Špoljar S
Acta Dermatovenerol Croat; 2019 Sep; 27(3):163-168. PubMed ID: 31542060
[TBL] [Abstract][Full Text] [Related]
31. Histogenesis of malignant melanoma of the skin: the role of lymphocytes in the transformation of tissue developmental units.
Palacios Llopis S
Med Hypotheses; 1989 Dec; 30(4):231-40. PubMed ID: 2615684
[TBL] [Abstract][Full Text] [Related]
32. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
[TBL] [Abstract][Full Text] [Related]
34. Reflectance-mode confocal microscopy for the in vivo characterization of pagetoid melanocytosis in melanomas and nevi.
Pellacani G; Cesinaro AM; Seidenari S
J Invest Dermatol; 2005 Sep; 125(3):532-7. PubMed ID: 16117795
[TBL] [Abstract][Full Text] [Related]
35. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma.
Holman CD; Armstrong BK; Heenan PJ
J Natl Cancer Inst; 1983 Oct; 71(4):651-6. PubMed ID: 6578359
[No Abstract] [Full Text] [Related]
36. [Segregation of pigment cell anomalies in Munich miniature swine (MMS) Troll crossed with German Landrace].
Müller S; Wanke R; Distl O
Dtsch Tierarztl Wochenschr; 1995 Oct; 102(10):391-4. PubMed ID: 8591738
[TBL] [Abstract][Full Text] [Related]
37. Dynamic gene expression analysis links melanocyte growth arrest with nevogenesis.
Yang G; Thieu K; Tsai KY; Piris A; Udayakumar D; Njauw CN; Ramoni MF; Tsao H
Cancer Res; 2009 Dec; 69(23):9029-37. PubMed ID: 19903842
[TBL] [Abstract][Full Text] [Related]
38. Mutations of the BRAF gene in benign and malignant melanocytic lesions.
Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA
J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620
[TBL] [Abstract][Full Text] [Related]
39. NIH consensus panel report: Precursors to malignant melanoma.
Md State Med J; 1984 Jul; 33(7):532-5. PubMed ID: 6547989
[No Abstract] [Full Text] [Related]
40. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment.
Seftor EA; Brown KM; Chin L; Kirschmann DA; Wheaton WW; Protopopov A; Feng B; Balagurunathan Y; Trent JM; Nickoloff BJ; Seftor RE; Hendrix MJ
Cancer Res; 2005 Nov; 65(22):10164-9. PubMed ID: 16288000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
